Reimagining psoriatic disease: A dermatologist’s perspective
Speaker: Prof. Alice Gottlieb
In this short summary video, Prof. Gottlieb discusses the role dermatologists can play in detecting PsA as well as the diagnostic tools that can be used to help achieve an early diagnosis.
Improving outcomes in early PsA: A rheumatologist’s perspective
Speaker: Prof. Georg Schett
In this short summary video, Prof. Schett discusses the rheumatologist’s perspective of the early phases of PsA and the importance of limiting progression from psoriasis and intercepting early PsA disease.
Discussion and Q&A
Speakers: Prof. Alice Gottlieb & Prof. Georg Schett
This session, which is moderated by Prof. Gravallese, addresses questions submitted by the audience. As part of this discussion, Prof. Gottlieb and Prof. Schett present a dermatologist’s and rheumatologist’s perspective on the importance of limiting psoriasis progression as well as intercepting PsA at the earliest stage possible.
Putting the patient first: Early intervention to improve outcomes in axSpA
Speakers: Prof. Helena Marzo-Ortega
In this short summary video, Prof. Marzo-Ortega presents two parallel case studies which demonstrate the impact of delays in diagnosis on pain, mobility, and overall quality of life for patients with axSpA.
PsA treatment recommendation: Focus on IL-17 inhibition
Speaker: Dr. Laura Coates
In this short summary video, Dr. Coates presents the recent updates to the GRAPPA treatment recommendations in PsA, and also discusses IL-17A inhibition data in terms of efficacy and safety data across the key manifestations of psoriatic disease.
Reimagining the standard of care in PsA and axSpA – Q&A and closing remarks
Speaker: Prof. Ellen Gravallese
Prof. Gravallese chairs the final Q&A session with the whole faculty and concludes the symposium by summarizing key learnings from each session.
